Sackler family accused of transferring money to Switzerland
The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion (CHF990 million) to themselves, New York’s attorney-general contends in court papers filed on Friday.
This content was published on
3 minutes
AP/ts
New York – asking a judge to enforce subpoenas of companies, banks and advisers to Purdue and its owners, the Sackler family – said it had uncovered the previously unknown wire transfers among family members, entities they control and several financial institutions.
The transfers bolster allegations by New York and other states that the Sacklers worked to shield their wealth in recent years because of mounting worries about legal threats.
Scores of those transactions sent millions of dollars to Mortimer D.A. Sackler, a former member of Purdue’s board and a son of one of its founders, according to the filings.
They point to $20 million shifted from a Purdue parent company to Sackler, who then redirected substantial amounts to shell companies that own family homes in Manhattan and the Hamptons. Another $64 million in transfers to Sackler came from a previously unknown family trust, using a Swiss account, prosecutors said in their filing.
The filing, made in a New York court, follows decisions by that state and others to reject a tentative settlement with Stamford, Connecticut-based Purdue, announced this week, arguing it doesn’t do enough to make amends for the company’s and family’s alleged roles in flooding US communities with prescription painkillers.
A spokesperson for Mortimer D.A. Sackler called the attorney-general’s contention an attempt to “torpedo a mutually beneficial settlement that is supported by so many other states and would result in billions of dollars going to communities and individuals across the country that need help”.
The transfers were “perfectly legal and appropriate in every respect”, the spokesperson said.
Subpoenas
As part of the settlement, Purdue is likely to soon file for bankruptcy protection. But New York and other states have promised they will continue to pursue the Sacklers, alleging that family members drained more than $4 billion from the company over the past dozen years. The family has used a complex chain of companies and trusts to control their holdings, some located in offshore tax havens.
The Sacklers had an estimated net worth of $13 billion as of 2016, making them America’s 19th-richest family, according to Forbes magazine.
In its filing on Friday, New York told a state judge that the only way it can determine the full extent of those transfers is if all those it has subpoenaed are forced to provide documents detailing their interactions with the Sackler family.
“While the Sacklers continue to lowball victims and skirt a responsible settlement, we refuse to allow the family to misuse the courts in an effort to shield their financial misconduct. The limited number of documents provided to us so far underscore the necessity for compliance with every subpoena,” New York Attorney-General Letitia James said in a prepared statement.
More
More
Opioid painkiller prescriptions surge in Switzerland
This content was published on
Prescription for powerful opioid medication have increased twenty-fold in the last thirty years, a recent study has found.
International cooperation: the National Assembly accepts 11 billion euros
This content was published on
Switzerland's international cooperation strategy 2025-2028 has been recommended a budget of almost CHF11 billion after weeks of political wrangling.
Zurich court throws out ‘cum-ex’ case against German lawyer
This content was published on
A trial against a German lawyer, accused of breaching Swiss banking secrecy investigating 'cum-ex' transactions, has collapsed.
Swiss National Bank lowers key interest rate by 0.5%
This content was published on
The Swiss National Bank lowers benchmark interest rate by a surprisingly hefty 0.5%. The reference rate now stands at 0.5%.
Swiss fintech Leonteq has profits confiscated after regulatory breach
This content was published on
Swiss derivatives firm Leonteq acted in serious violation of regulatory obligations and must to hand over CHF9.3 million in profits.
This content was published on
Sandoz Inc. and Pear Therapeutics announced that that an app to help treat opium addicts was approved in the United States.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.